Skip to main content

Table 1 Patient characteristics (laboratory data obtained on the day of Seraph® treatment)

From: Hemofiltration with the Seraph® 100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients

  # 1 # 2 # 3 # 4 # 5 # 6 # 7
Gender M F M M F M M
Age (years 77 78 54 41 61 65 72
Weight (kg) 76.5 75 107 119 122 60.5 71
Height (cm) 164 160 188 180 168 166 175
Onset of symptoms-Seraph treatment (d) 5 19 10 13 9 16 12
Died @ hospital day 60 9 7 Survivor Survivor Survivor 18
N-protein before Seraph therapy (pg/mL) 1021.3 26.6 121,884.2 1070.2 1036.5 19.5 -
N-protein after Seraph therapy (pg/mL) 769.6 24.1 111,035.2 931.5 376.2 12.1 -
CRP (mg/l) 73 443 87 110 156 129 39
Ferritin (ng/mL) 2957 830 10,005 838 589 756 1,412
PCT (µg/L) 0.7 18.5 4.4 1.1 0.1 0.1 0.1
D-dimer (mg/L) 4.68 35.2 3.26 1.04 0.90 4.00 35.2
Therapy (h) IHD (4) CRRT (24) IHD (4) IHD (5) HP (15) HP (4) HP (14)
Qb (mL/min) 300 90 250 250 80 200 100
  1. IHD intermittent hemodialysis, CRRT continuous renal replacement therapy, HP hemoperfusion, Qb blood flow